Many bacterial species that are able to degrade such compounds have been described to date.
More than 800 eukaryotic viridiplantae chloroplast genomes have been described to date (http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.cgi taxid=2759&opt=plastid).nih.gov/genomes/GenomesGroup.cgi taxid=2759&opt=plastid
No specific function or receptor targets for ANA have been described to date.
However, the intraoperative use of this technique has not been described to date.
The system of pedagogic modalities is the most complex system described to date for pedagogic register.
The largest cohort described to date was recently published and included 565 patients [8].
However, RNA-QSAR studies on RNA molecules have not been described to date.
A review of all Erg11 amino acid polymorphisms described to date is given.
Compounds 8b and 15c are the most potent triple inhibitors described to date.
Tissue constructs for cartilage with native mechanical properties have not been described to date.
